MRE plus FIB-4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Nobuharu TamakiKento ImajoSuzanne SharptonJinho JungNobuyoshi KawamuraMasato YonedaMark A ValasekCynthia BehlingClaude B SirlinNobuyoshi KawamuraRohit L LoombaPublished in: Hepatology (Baltimore, Md.) (2021)
MEFIB has higher diagnostic accuracy than FAST for significant fibrosis in NAFLD, and our results support the utility of a two-step strategy for detecting significant fibrosis in NAFLD.
Keyphrases